BREAKTHROUGH ORTHOPAEDIC TECHNOLOGY

Preserves The Joint.
Reclaim Your Life

Medel's Arthrelis is a modern, joint-preserving surgical technology for the treatment of osteoarthritis. Our innovative implant reduces pain syndrome, halts progressive joint degeneration, and delays the need for total joint replacement.

86-88%Reduction in WOMAC ScoresMeasuring Pain & Stiffness
74.5%Avoidance of Joint ReplacementLong-Term Follow-up
1000sPatients Helped Worldwide

THE UNMET NEED

Bridging the Gap in Joint Care

Millions of patients with moderate osteoarthritis face a therapeutic void. Too advanced for conservative treatment, but not yet candidates for joint replacement. Arthrelis addresses this critical unmet need.

KL Grade I

Rehab & Medications

Temporarily masks symptoms while cartilage degrades

KL Grade II

IMPLESO — The Solution

The first and only device that modifies disease progression

KL Grade III & IV

Joint Replacement

Major surgery with significant recovery time

Arthrelis is the first and only device designed to modify disease progression in the treatment gap between conservative care and joint replacement.

PATIENTS

Reclaim Your Life Without Major Surgery 

For decades, treating advanced osteoarthritis meant inevitably facing the daunting prospect of total joint replacement.  The fear of losing independence, enduring a difficult recovery, and facing high costs forces millions of patients to endure escalating joint pain in silence. 

MINIMALLY INVASIVE

Short 20–30 Minute Surgery

IMPLESO® is implanted through a minimally invasive, organ-preserving surgical approach. No joint destruction. No major incision. Just a brief procedure with lasting disease-modifying effect.

KNEE OSTEOARTHRITIS

Shorter Hospital Stay

Surgeries can be performed at outpatient surgery centers, allowing patients to return home quickly with no lengthy hospital stay.

ECONOMICAL · COMPATIBLE

A Fraction of the Cost

Arthrelis is highly economical compared to total joint replacement, allowing for cost-effective treatment compared to total joint replacement.

"It's just one simple procedure for years of disease modification. We aren't just repairing a joint, we are restoring function, mobility, and quality of life."

CLINICAL APPLICATIONS

One Mechanism Of Action.
Multiple Orthopaedic Uses.

Our technology is not limited to a single joint or a single condition. Arthrelis has been clinically validated across four distinct orthopedic indications, demonstrating the versatility of bio-electric bone regeneration technology.

01

Knee Osteoarthritis

For patients with Stage II osteoarthritis too advanced for conservative care but not yet candidates for joint replacement. A minimally invasive, joint-preserving alternative.

02

Perthes Disease

Pediatric hip condition causing bone deterioration. IMPLESO demonstrated 86–88% excellent outcomes with sustained bone regeneration over 5+ years of follow-up.

03

Hip Osteoarthritis

Avascular necrosis of the femoral head. Published data: 74% of patients avoided hip replacement surgery within 2 years. Measurable bone regeneration on imaging.

04

Trauma Non-Unions

Fractures that fail to heal naturally. 97% healing rate in chronic non-unions. The electret stimulates osteogenesis at the fracture site, promoting union without external devices.

GET IN TOUCH

Partner With Us

Whether you're a surgeon exploring new treatment options, a distributor seeking innovative products, or a strategic partner interested in bio-electric medicine, we'd like to hear from you.

For Surgeons

Explore a minimally invasive, joint-preserving treatment backed by 20+ years of clinical evidence. Learn how Arthrelis can expand your practice.

For Distributors

Bring a first-in-class orthopedic device to your market. Arthrelis is commercially available and expanding internationally with regulatory approvals in place.

For Strategic Partners

Collaborate on the future of bio-electric medicine. We welcome partnerships in research, manufacturing, and market development across orthopedic indications.